DO STATINS IMPROVE LUNG FUNCTION IN ASTHMATIC PATIENTS? A RANDOMIZED AND DOUBLE-BLIND TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FAHIMI F.; SALAMZADEH J.; JAMAATI H.R.; SOHRABI S.; FAKHARIAN A.; MOHAMMAD TAHERI Z.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Pharmaceutical Sciences Year:2009 | Volume:5 | Issue:1 Page(s): 13-20

Download Full-Text

View:

357

Download:

116

Cites:

Information Journal Paper

Title

DO STATINS IMPROVE LUNG FUNCTION IN ASTHMATIC PATIENTS? A RANDOMIZED AND DOUBLE-BLIND TRIAL

Author(s)

Keywords

ASTHMA

ATORVASTATIN

CLINICAL TRIALS

LUNG FUNCTION

STATIN

Abstract

There are evidences that STATINs have anti-inflammatory effects beyond their cholesterol lowering properties. The study was conducted to assess the effects of ATORVASTATIN on ASTHMA as an inflammatory disease. Patients with moderate to severe ASTHMA were entered this randomized, double blind, crossover clinical trial. The impact of oral ATORVASTATIN (10 mg/day) on the LUNG FUNCTION of normolipidemic patients was studied. The study was conducted in the National Research Institute of Tuberculosis and Lung Disease. Patients were randomized to receive either ATORVASTATIN or placebo for 4 weeks separated by a 2-week washout period in a crossover fashion. Patients continued on their usual ASTHMA drug treatment throughout the study. Spirometric parameters were determined at baseline and at completion of drug or placebo administration. Seventeen patients with the age of 37.12±12.41 years completed the trial. Data analysis revealed no significant differences in peak expiratory flow rate (PEF), forced expiratory volume in the first second (FEV1), forced vital capacity (FVC) and FEV1/FVC between placebo and ATORVASTATIN therapy. The results showed no significant improvement in the pulmonary function tests in ASTHMAtic patients receiving ATORVASTATIN. Further studies using higher doses of STATINs and/or higher period of STATIN use are recommended.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

FAHIMI, F., SALAMZADEH, J., JAMAATI, H.R., SOHRABI, S., FAKHARIAN, A., & MOHAMMAD TAHERI, Z.. (2009). DO STATINS IMPROVE LUNG FUNCTION IN ASTHMATIC PATIENTS? A RANDOMIZED AND DOUBLE-BLIND TRIAL. IRANIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 5(1), 13-20. SID. https://sid.ir/paper/300253/en

Vancouver: Copy

FAHIMI F., SALAMZADEH J., JAMAATI H.R., SOHRABI S., FAKHARIAN A., MOHAMMAD TAHERI Z.. DO STATINS IMPROVE LUNG FUNCTION IN ASTHMATIC PATIENTS? A RANDOMIZED AND DOUBLE-BLIND TRIAL. IRANIAN JOURNAL OF PHARMACEUTICAL SCIENCES[Internet]. 2009;5(1):13-20. Available from: https://sid.ir/paper/300253/en

IEEE: Copy

F. FAHIMI, J. SALAMZADEH, H.R. JAMAATI, S. SOHRABI, A. FAKHARIAN, and Z. MOHAMMAD TAHERI, “DO STATINS IMPROVE LUNG FUNCTION IN ASTHMATIC PATIENTS? A RANDOMIZED AND DOUBLE-BLIND TRIAL,” IRANIAN JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 5, no. 1, pp. 13–20, 2009, [Online]. Available: https://sid.ir/paper/300253/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops